# FDA Inspection 824820 - Hikma Pharmaceuticals USA Inc. - March 28, 2013

Source: https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/e7321373-059d-4731-84dd-845fc39c9c3e
Source feed: FDA_Inspections

> FDA Inspection 824820 for Hikma Pharmaceuticals USA Inc. on March 28, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 824820
- Company Name: Hikma Pharmaceuticals USA Inc.
- Inspection Date: 2013-03-28
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1237333 - 2024-06-12](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/c508334e-3cc5-450a-a665-5fb2a067f1ed)
- [FDA Inspection 1222115 - 2023-11-03](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/e7b030d5-aa1b-472b-8874-97ba0cb35d84)
- [FDA Inspection 1176451 - 2022-07-07](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/fec1c4c9-b369-4a8b-b7d4-95bbcf2bb527)
- [FDA Inspection 1106822 - 2019-09-10](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/607fb2a5-7932-4aff-a16c-1afe2023de82)
- [FDA Inspection 1067645 - 2018-09-14](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/c059d905-bd50-4a5b-89f7-1709212bd9d1)

Company: https://www.keypedia.com/companies/hikma-pharmaceuticals-usa-inc/646ab738-7dde-4473-abdb-76058836c610

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c